NYSEAMERICAN:SENS - Senseonics Stock Price, Forecast & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Senseonics.

Senseonics is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Senseonics.

Senseonics Holdings Inc (NYSEAMERICAN:SENS) announced its quarterly earnings data on Thursday, March, 12th. The company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The company had revenue of $9 million for the quarter, compared to the consensus estimate of $7.93 million. View Senseonics' earnings history.

Senseonics updated its FY 2020 After-Hours earnings guidance on Thursday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $15-20 million, compared to the consensus revenue estimate of $36.29 million.

7 brokerages have issued 12-month price objectives for Senseonics' shares. Their forecasts range from $0.40 to $2.00. On average, they expect Senseonics' share price to reach $1.43 in the next year. This suggests a possible upside of 116.7% from the stock's current price. View analysts' price targets for Senseonics.

Media stories about SENS stock have trended extremely negative recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Senseonics earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutSenseonics.

Senseonics saw a increase in short interest in February. As of February 14th, there was short interest totaling 37,420,000 shares, an increase of 6.6% from the January 30th total of 35,100,000 shares. Based on an average trading volume of 1,360,000 shares, the short-interest ratio is presently 27.5 days. Approximately 36.5% of the company's shares are short sold. View Senseonics' Current Options Chain.

Some companies that are related to Senseonics include Integral Diagnostics (IDX), Volpara Health Tech (VHT), Profound Medical (PRN), Exagen (XGN), Akumin (AKU), Renalytix Ai (RENX), Palatin Technologies (PTN), Yourgene Health (YGEN), Oncosil Medical (OSL), MaxCyte (MXCT), Lexagene (LXG), BARD1 Life Sciences (BD1), Oncimmune (ONC), GeneNews (GEN) and Sernova (SVA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include Agile Therapeutics (AGRX), Amarin (AMRN), Crispr Therapeutics (CRSP), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Tandem Diabetes Care (TNDM), VirnetX (VHC), Melinta Therapeutics (MLNT), Micron Technology (MU) and Nabriva Therapeutics (NBRV).

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics' stock is owned by a number of institutional and retail investors. Top institutional investors include Delphi Management Partners VIII L.L.C. (4.84%), Silverback Asset Management LLC (1.34%), State Street Corp (0.91%), Geode Capital Management LLC (0.83%), Raymond James & Associates (0.52%) and Raymond James Financial Services Advisors Inc. (0.30%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain and Timothy T Goodnow. View institutional ownership trends for Senseonics.

SENS stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, State Street Corp, UBS Group AG, Bank of America Corp DE, Raymond James & Associates, Bank of New York Mellon Corp, Daiwa Securities Group Inc., and Raymond James Financial Services Advisors Inc.. View insider buying and selling activity for Senseonics.

SENS stock was acquired by a variety of institutional investors in the last quarter, including Delphi Management Partners VIII L.L.C., Virtu Financial LLC, Geode Capital Management LLC, Magnus Financial Group LLC, Spark Investment Management LLC, Palisade Capital Management LLC NJ, Trust Co. of Oklahoma, and Goldman Sachs Group Inc.. View insider buying and selling activity for Senseonics.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $0.66.

Senseonics has a market capitalization of $134.28 million. Senseonics employs 192 workers across the globe. View additional information about Senseonics.

The official website for Senseonics is http://www.senseonics.com/.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.